Home » Drug Information » FDA-Approved Drugs » 1997
Medical Areas: Dermatology/Plastic Surgery
View By: Year Company Therapeutic Areas Drug Names
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Penederm
Approval Status: Approved December 1997
Treatment Area: athlete's foot
A one-week dosing regimen for Mentax has been approved for the
treatment of athlete's foot. The dosing regimen allows topical
application either twice-a-day for seven days, or once-a-day for
four weeks for more severe cases of the fungus. Mentax is the only
topical antifungal product approved in the U.S. which has such a
one-week dosing regimen.
